Penwest Pharmaceuticals Co.

penwest pharmaceuticals co. - All News and Analysis

• Penwest Pharmaceuticals Co. Q3 2008 Earnings Call Transcript

  Seeking Alpha - 2008-11-20

  Question-and-Answer SessionOperator Operator instructions We have a question from Ken Trbovich. Ken Trbovich – RBC Capital Markets Thanks for taking the question. I guess just really quickly, Ben, if you could go back on that patent impairment charge, was it $490,000 or $440,000? Ben Palleiko $490,000....

  Tags: Payment, Call Transcript, Earnings, RBC Capital Markets, Penwest Pharmaceuticals Co., Operational Accounting, Finance, Seeking Alpha

• Penwest Pharmaceuticals Co. Q2 2008 Earnings Call Transcript

  Seeking Alpha - 2008-09-05

  Question-and-Answer SessionOperator Operator instructions Your first question is from Ian Sanderson with Cowen & Company. Ian Sanderson – Cowen & Company Good morning. Thanks for taking the question. First, and I’m not sure if you can answer this, but I’ll give it a shot, any update you...

  Tags: Penwest Pharmaceuticals Co.

• Penwest Pharmaceuticals Co. Q1 2008 Earnings Call Transcript

  Seeking Alpha - 2008-05-30

  Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line Bert Hazlett. Bert Hazlett - BMO Capital Markets Thanks for taking the question, good morning everybody. Could you just maybe elucidate a little bit better the status of the Opana ER discussions in Europe? And then could you...

  Tags: Penwest Pharmaceuticals Co.

• Penwest Pharmaceuticals Co. Q4 2007 Earnings Call Transcript

  Seeking Alpha - 2008-04-17

  Question-and-Answer SessionOperator Operator Instructions. And your first question comes from the line of Jeff Goater with Cowen & Company. Jeff Goater – Cowen & Company Hi, good morning, thanks for taking my question. Ben, I know, you’re not providing financial guidance but can you give us a sense...

  Tags: Penwest Pharmaceuticals Co.

• Endo and Penwest Receive New Paragraph IV Certification Notice From IMPAX for OPANA(R) ER

  - 2007-12-17

  Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) and Penwest Pharmaceuticals Co. (NASDAQ: PPCO) announced today that on December 14, 2007, they received a notice from IMPAX Laboratories, Inc. advising of the FDA's acceptance for substantive review, as of November 23, 2007, of IMPAX's Abbreviated New Drug Application ANDA containing a...

  Tags: FDA, Penwest Pharmaceuticals Co.

• Penwest Pharmaceuticals Q3 2007 Earnings Call Transcript

  Seeking Alpha - 2007-11-02

  Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Jeff Goater with Cowen & Company. Jeff Goater - Cowen & Company Thanks for taking the questions. Ben, just on the Otsuka arrangement in terms of the revenues that you guys booked during the quarter, is that...

  Tags: Penwest Pharmaceuticals Co.

• Market Alerts: ISNY! October 4, 2007

  - 2007-10-04

  Stock Market Alerts' performance stock list includes: Internet Song of the Year, Inc. (PINKSHEETS: ISNY), Penwest Pharmaceuticals Co. (NASDAQ: PPCO), NutriSystem (NASDAQ: NTRI), LDK Solar Co., Ltd. (NYSE: LDK). Having just released breaking news, Internet Song of the Year, Inc. (PINKSHEETS: ISNY) should have investors closely monitoring the stock...

  Tags: Company, FINANCE, INTERNET, Investment, Nasdaq Stock Market Inc., NutriSystem, Penwest Pharmaceuticals Co., stock

• Penwest looks to Danbury for temporary corporate home.(Penwest Pharmaceuticals considers former Union Carbide Corp. headquarters)

  - 2002-11-25

  The former Union Carbide headquarters in Danbury may soon be the temporary corporate headquarters of Penwest Pharmaceuticals, according to Jennifer Good, Penwest chief financial officer. Research and development staff will stay in Penwest's current l The former Union Carbide headquarters in Danbury may soon be the...

  Tags: Penwest Pharmaceuticals Co.

• Penwest, Ranbaxy in pact. (Business - In Brief).(Nifedipine XL blood pressure prep)(Brief Article)

  - 2002-03-04

  Penwest Pharmaceuticals Company has granted Ranbaxy Laboratories Ltd. exclusive marketing rights in select markets for the hypertension drug ... Penwest Pharmaceuticals Company has granted Ranbaxy Laboratories Ltd. exclusive marketing rights in select markets for the hypertension drug Nifedipine XL, a controlled release version...

  Tags: blood pressure, Penwest Pharmaceuticals Co.

• Penwest Pharmaceuticals Co. (Supplier Briefs).(development joint venture with Martin Bauer Group)(Brief Article)

  - 2002-02-01

  Penwest Pharmaceuticals Co., Patterson, N.Y. has said its Prosolv technology will be used ... Penwest Pharmaceuticals Co., Patterson, N.Y. has said its Prosolv technology will be used in a new line of herbal supplement formulations to be co-developed by the Martin Bauer Group.

  Tags: Penwest Pharmaceuticals Co., supplier

• National Securities Corporation Announces Investment Opinion on Penwest Pharmaceuticals Co

  - 2001-09-05

  Business Editors NOTE TO EDITORS: The following is an investment opinion issued by National Securities Corporation SEATTLE--BUSINESS WIRE--Sept. 5, 2001 National Securities Corporation Initiates Coverage of Penwest Pharmaceuticals Co. (Nasdaq: PPCO) With $34/Share Price Target National Securities Corp. today announced that it has initiated...

  Tags: Nasdaq Stock Market Inc., Penwest Pharmaceuticals Co.

Additional Resources

• Barr Confirms Patent Challenge of Opana® ER Extended-Release Tablets, 5 mg, 10 mg, 20 mg and 40 mg

  - 2008-10-21

  MONTVALE, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Endo Pharmaceuticals Inc. in connection with its OpanaR ER oxymorphone hydrochloride extended-release tablets, 5 mg, 10 mg, 20 mg and 40 mg....

• IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana® ER

  - 2008-07-28

  HAYWARD, Calif. -- IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc. ("Endo") and Penwest Pharmaceuticals, Co. ("Penwest") have filed suit for patent infringement based on the Company's amendment to its existing Abbreviated New Drug Application ("ANDA") for oxymorphone hydrochloride extended-release tablets CII, generic of Opana[R] ER, adding new 7.5 mg,...

• Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer

  - 2008-07-07

  EWING, N.J. -- Antares Pharma, Inc. (AMEX:AIS) announced that Paul K. Wotton, Ph.D., has joined Antares Pharma as President and Chief Operating Officer. Dr. Wotton has over 20 years experience in the pharmaceutical industry with both large and specialty pharma companies. Previously, Dr. Wotton served as CEO of...

• Endo and Penwest File Lawsuit Against Actavis Relating to Opana(R) ER

  - 2008-03-28

  Endo Pharmaceuticals Inc.,a subsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), andPenwest Pharmaceuticals Co. (NASDAQ: PPCO) announced today that they havefiled a lawsuit against Actavis South Atlantic LLC in the United StatesDistrict Court for the District of New Jersey in connection with Actavis'sAbbreviated New Drug Application ANDA for OPANA® ER...

• Endo and Penwest Receive Paragraph IV Certification Notice From Actavis for OPANA(R) ER

  - 2008-02-15

  Endo PharmaceuticalsHoldings Inc. (NASDAQ: ENDP) and Penwest Pharmaceuticals Co. (NASDAQ: PPCO)announced today that on February 14, 2008, they received a notice fromActavis South Atlantic LLC advising of the filing by Actavis of anAbbreviated New Drug Application ANDA containing a Paragraph IVcertification under 21 U.S.C. Section 355j for oxymorphone hydrochlorideextended-release tablets...

• Introduces Penwest Pharmaceuticals to our Bluechips Radar.

  - 2008-02-05

  M2 PRESSWIRE-5 February 2008-IST Market Review: Introduces Penwest Pharmaceuticals to our Bluechips RadarC1994-2008 M2 COMMUNICATIONS LTD RDATE:05022008 International Stock Targets is a world renowned independent research firm, based in Johannesburg, South Africa. Along with walking investors through the whole...

• Endo and Penwest File Lawsuit Against Impax Laboratories Relating to OPANA(R) ER

  - 2008-01-25

  Endo Pharmaceuticals Inc.,a subsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), andPenwest Pharmaceuticals Co. (NASDAQ: PPCO) announced today that they havefiled a lawsuit against IMPAX Laboratories, Inc. in the United StatesDistrict Court for the District of Delaware in connection with IMPAX'sAbbreviated New Drug Application ANDA for OPANA® ER oxymorphone HClextended-release...

• IMPAX Comments on Lawsuit Related to Generic Version of Opana® ER

  - 2007-11-19

  HAYWARD, Calif. -- IMPAX Laboratories, Inc. (OTC:IPXL) today confirmed that Endo Pharmaceuticals Holdings Inc. and Penwest Pharmaceuticals Co. have filed a lawsuit against the Company in the United States District Court for the District of Delaware alleging patent infringement related to IMPAX's filing of an Abbreviated New Drug Application ANDA...

• Endo and Penwest File Lawsuit Against IMPAX Laboratories Relating to OPANA(R) ER

  - 2007-11-15

  Endo Pharmaceuticals Inc., asubsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), andPenwest Pharmaceuticals Co. (NASDAQ: PPCO) announced today that they havefiled a lawsuit against IMPAX Laboratories, Inc. in the United StatesDistrict Court for the District of Delaware in connection with IMPAX'sAbbreviated New Drug Application ANDA for OPANA® ER oxymorphone HClextended-release...

• Incorporated: 1991
• CEO: Ms. Jennifer L. Good CPA